AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Illumina to Announce First Quarter 2019 Financial Results on Thursday, April 25, 2019

April 9, 2019

SAN DIEGO--(BUSINESS WIRE)--Apr 9, 2019--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for first quarter 2019 following the close of market on Thursday, April 25, 2019.

On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, President and Chief Executive Officer, and Sam Samad, Senior Vice President and Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Thursday, April 25, 2019. Interested parties may access the live teleconference through the Investor Relations section of Illumina’s website under the “company” tab at www.illumina.com. Alternatively, individuals can access the call by dialing 1 (844) 647-5490 or 1 (615) 247-0295 outside North America, both with conference ID 9153579.

A replay of the conference call will be posted on Illumina’s website after the event and will be available for at least 30 days following.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit  www.illumina.com  and follow @illumina.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190409005992/en/

CONTACT: Investors:

Jacquie Ross, CFA

858-882-2172

ir@illumina.comMedia:

Eric Endicott

858-882-6822

pr@illumina.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS

SOURCE: Illumina, Inc.

Copyright Business Wire 2019.

PUB: 04/09/2019 04:04 PM/DISC: 04/09/2019 04:04 PM

http://www.businesswire.com/news/home/20190409005992/en